ストックスクリーナーアプリを入手
1.14
2.70%
0.03
前日終値:
$1.11
開ける：
$1.1
24時間の取引高:
492.30K
Relative Volume:
0.64
時価総額：
$93.69M
収益：
$361.07M
当期純損益:
$-71.54M
株価収益率:
-1.443
EPS:
-0.79
ネットキャッシュフロー:
$-47.97M
1週間 パフォーマンス:
+14.43%
1か月 パフォーマンス:
+28.08%
6か月 パフォーマンス:
+268.22%
1年 パフォーマンス:
-27.85%
1日の値動き範囲:
$0.97
$1.2094
1週間の範囲:
$0.97
$1.4286
52週間の値動き範囲:
$0.1253
$1.63
Oncology Institute Inc Stock (TOI) Company Profile
TOI を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TOI
Oncology Institute Inc
|
1.14 | 93.69M | 361.07M | -71.54M | -47.97M | -0.79 |
|
HCA
Hca Healthcare Inc
|
342.16 | 84.29B | 70.60B | 5.76B | 5.64B | 21.97 |
|
FMS
Fresenius Medical Care Ag Adr
|
24.78 | 14.41B | 20.87B | 715.14M | 1.67B | 1.2209 |
|
DVA
Davita Inc
|
150.22 | 13.37B | 12.67B | 827.68M | 1.42B | 9.27 |
|
THC
Tenet Healthcare Corp
|
133.14 | 13.01B | 20.97B | 3.13B | 2.39B | 31.21 |
|
UHS
Universal Health Services Inc
|
186.18 | 11.80B | 15.42B | 1.03B | 956.84M | 15.02 |
Oncology Institute Inc Stock (TOI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-02-26 | 再開されました | Jefferies | Buy |
| 2022-09-14 | 開始されました | Guggenheim | Buy |
| 2022-08-15 | 開始されました | Jefferies | Buy |
Oncology Institute Inc (TOI) 最新ニュース
Oncology Institute Executives Make Bold Moves with Major Stock Purchases - TipRanks
The oncology institute targets profitability and $460M-$480M revenue in 2025 - MSN
Oncology institute director Mark Pacala acquires $94,338 in stock By Investing.com - Investing.com South Africa
Oncology institute’s COO Jeremy Castle makes $9,433 stock purchase - Investing.com India
Oncology institute’s chief medical officer buys $9,433 in stock - Investing.com
Oncology institute CFO Robert Ross buys $9,433 in stock - Investing.com India
Oncology institute director Richard Barasch acquires $1.42 million in shares - Investing.com India
Oncology Institute, Inc. Earnings Call: Growth Amid Challenges - MSN
The Oncology Institute, Inc. (NASDAQ:TOI) Q4 2024 Earnings Call Transcript - Insider Monkey
The Oncology Institute Inc (TOI) Q4 2024 Earnings Call Highlights: Navigating Growth Amidst ... By GuruFocus - Investing.com Canada
The Oncology Institute Reports Strong Q4 Revenue Growth - TipRanks
Earnings call transcript: Oncology Institute Q4 2024 results show strategic growth - Investing.com Australia
Earnings call transcript: Oncology Institute Q4 2024 results show strategic growth By Investing.com - Investing.com South Africa
The Oncology Institute Announces $16.5 million Private Placement - GlobeNewswire
The Oncology Institute Secures $16.5 Million In Private Placement - Nasdaq
Oncology Institute, Inc. Prepares for PIPE Financing - TipRanks
The Oncology Institute, Inc. Announces $16.5 Million Private Placement Agreement - Nasdaq
Oncology Institute Achieves 17% Growth: Mixed Q4 Results Show Path to Profitability - StockTitan
The Oncology Institute Reports Fourth Quarter and Full Year 2024 Financial Results and Guidance for 2025 - GlobeNewswire
Oncology Institute Lands Major $16.5M Backing as Insiders Double Down - StockTitan
Wilmot Cancer Institute earns prestigious National Cancer Institute designation - THE WELLSVILLE SUN
Ginsenoside Supplement Redsenol-1 Plus Included in National Cancer Institute's Drug Dictionary - 24-7 Press Release
The Oncology Institute Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call - GlobeNewswire
TOIThe Oncology Institute Inc Latest Stock News & Market Updates - StockTitan
The Oncology Institute, Inc. Scheduled to Release Q4 and Full Year 2024 Financial Results on March 25, 2025 - Nasdaq
Market Cool On The Oncology Institute, Inc.'s (NASDAQ:TOI) Revenues Pushing Shares 28% Lower - Simply Wall St
When Will The Oncology Institute Report Q4 2024 Earnings? Key Date for TOI Investors - StockTitan
The Oncology Institute, Inc. (NASDAQ:TOI) Sees Significant Increase in Short Interest - MarketBeat
The Oncology Institute, Inc. (NASDAQ:TOI) Short Interest Up 188.3% in February - Defense World
Oncology Institute Amends Facility Agreement with Deerfield - TipRanks
The Oncology Institute Announces Amendment to Facility Agreement and Debt Paydown - The Manila Times
TOI Slashes Debt While Expanding Patient Base: What's Behind This Strategic Financial Move? - StockTitan
NCCN Announces New Gastrointestinal Cancer Research Grants in Collaboration with Taiho Oncology, Inc. - BioSpace
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Informs Shareholders of an Investigation into The Oncology - ACCESS Newswire
Oncology Institute (NASDAQ:TOI) Trading Down 6.9%Here's What Happened - MarketBeat
Oncology Institute (NASDAQ:TOI) Stock Price Down 6.9% – Time to Sell? - Armenian Reporter
A groundbreaking project at the Oncology Institute in Shaare Zedek Medical Center - The Jerusalem Post
Cancer Care - Cone Health
In the Green: Oncology Institute Inc (TOI) Closes at 0.82, Up/Down -7.68 from Previous Day - The Dwinnex
Oncology Institute Inc [TOI] Investment Appeal on the Rise - Knox Daily
Singapore Cancer Center opens in Cebu - SunStar Philippines
Market Insights: Oncology Institute Inc (TOI)’s Notable Drop of -3.75, Closing at 0.85 - The Dwinnex
Oncology Institute's Market Cap Up US$7.0m Following Year Of Insider Stock Buying - Yahoo Finance
Oncology Institute Inc (TOI) Stock: A Year of Market Fluctuations - The InvestChronicle
Oncology Institute Inc [TOI] Stock bought by Insider Hively Brad for $42500.0 - Knox Daily
The Oncology Institute Inc (TOI) had a good session last reading, didn’t it? - US Post News
Why The Oncology Institute (TOI) Is Skyrocketing So Far In 2025 - Insider Monkey
The Oncology Institute, Inc. (NASDAQ:TOI) Sees Large Growth in Short Interest - MarketBeat
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into The Oncology Institute, Inc. - ACCESS Newswire
The Oncology Institute, Inc. (NASDAQ:TOI) Stock Rockets 195% But Many Are Still Ignoring The Company - Simply Wall St
Guardant Health Shield Platform Selected for Inclusion in National Cancer Institute’s Vanguard Study to Evaluate Emerging Technologies for Multi-Cancer Detection - Business Wire
Oncology Institute Inc (TOI) 財務データ
収益
当期純利益
現金流量
EPS
Oncology Institute Inc (TOI) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Podnos Yale | Chief Medical Officer |
Mar 26 '25 |
Buy |
1.04 |
9,056 |
9,434 |
79,049 |
| Pacala Mark L | Director |
Mar 26 '25 |
Buy |
1.04 |
90,562 |
94,338 |
224,971 |
| Johnson Karen Marie | Director |
Mar 26 '25 |
Buy |
1.04 |
36,224 |
37,735 |
203,409 |
| Hively Brad | Director |
Mar 26 '25 |
Buy |
1.04 |
9,056 |
9,434 |
675,809 |
| Castle Jeremy | Chief Operating Officer |
Mar 26 '25 |
Buy |
1.04 |
9,056 |
9,434 |
90,386 |
| Carter Robert Ross | Chief Financial Officer |
Mar 26 '25 |
Buy |
1.04 |
9,056 |
9,434 |
39,407 |
| BARASCH RICHARD A | Director |
Mar 26 '25 |
Buy |
1.04 |
1,358,448 |
1,415,095 |
1,775,641 |
| Hively Brad | Director |
Nov 26 '24 |
Buy |
0.17 |
250,000 |
42,500 |
616,753 |
| Hively Brad | Director |
Dec 02 '24 |
Buy |
0.15 |
50,000 |
7,500 |
666,753 |
0.70%
0.23%
大文字化:
|
ボリューム (24 時間):